Related Experiment Video

Updated: Jul 7, 2026

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine
10:08

Tachycardia-Induced Cardiomyopathy As a Chronic Heart Failure Model in Swine

Published on: February 17, 2018

Indications for pacing in patients with congenital heart disease

Elisabeth Villain1

  • 1Cardiologie Pédiatrique, Université Paris V René Descartes, Hôpital Necker-Enfants Malades, Paris, France. elisabeth.villain@nck.aphp.fr

Pacing and Clinical Electrophysiology : PACE
|March 25, 2008
PubMed

Insights

Pacemaker implantation is now recommended for more pediatric congenital heart disease patients, not just for sudden death prevention. Pacing improves quality of life and can serve as a bridge to heart transplantation.

Area of Science:

  • Pediatric Cardiology
  • Electrophysiology
  • Congenital Heart Disease

Background:

  • Pacemaker technology advances have broadened indications for antibradycardia pacing.
  • New uses for pacing include treating atrial tachycardia and cardiac failure in congenital heart disease (CHD).

Purpose of the Study:

  • To outline current indications for cardiac pacing in pediatric patients with congenital heart disease.
  • To highlight the extended role of pacing beyond preventing sudden death.

Main Methods:

  • Review of established and emerging indications for pacemaker implantation in pediatric CHD.
  • Analysis of criteria for pacing in various age groups and clinical scenarios, including post-operative heart block.

Main Results:

  • Pacemaker implantation is mandatory for symptomatic complete atrio-ventricular block.
  • Specific heart rate thresholds and pause durations guide prophylactic pacing in neonates, infants, and older children.
  • Persistent post-operative heart block and specific electrophysiological findings necessitate pacing.
  • Atrial pacing and cardiac resynchronization therapy are viable options for specific CHD-related arrhythmias and heart failure.

Conclusions:

  • Cardiac pacing indications in CHD have expanded significantly.
  • Pacemaker implantation is crucial for improving quality of life in CHD patients.
  • Pacing serves as a vital bridge to cardiac transplantation for eligible patients.
Abstract

More Related Videos

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice08:05

Optimization of Transesophageal Atrial Pacing to Assess Atrial Fibrillation Susceptibility in Mice

Published on: June 29, 2022

Translational Rabbit Model of Chronic Cardiac Pacing06:14

Translational Rabbit Model of Chronic Cardiac Pacing

Published on: January 6, 2023

Related Concept Videos

Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias III: Characteristics of Dysrhythmias01:29

Dysrhythmias III: Characteristics of Dysrhythmias

Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per minute.
Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...